title: Genomic survey of prepulse inhibition in mouse chromosome substitution strains.
abstract: Prepulse inhibition (PPI) is a measure of sensorimotor gating, a pre-attentional inhibitory brain mechanism that filters extraneous stimuli. Prepulse inhibition is correlated with measures of cognition and executive functioning, and is considered an endophenotype of schizophrenia and other psychiatric illnesses in which patients show PPI impairments. As a first step toward identifying genes that regulate PPI, we performed a quantitative trait locus (QTL) screen of PPI phenotypes in a panel of mouse chromosome substitution strains (CSSs). We identified five CSSs with altered PPI compared with the host C57BL/6J strain: CSS-4 exhibited decreased PPI, whereas CSS-10, -11, -16 and -Y exhibited higher PPI compared with C57BL/6J. These data indicate that A/J chromosomes 4, 10, 11, 16 and Y harbor at least one QTL region that modulates PPI in these CSSs. Quantitative trait loci for the acoustic startle response were identified on seven chromosomes. Like PPI, habituation of the startle response is also disrupted in schizophrenia, and in the present study CSS-7 and -8 exhibited deficits in startle habituation. Linkage analysis of an F(2) intercross identified a highly significant QTL for PPI on chromosome 11 between positions 101.5 and 114.4 Mb (peak LOD = 4.54). Future studies will map the specific genes contributing to these QTLs using congenic strains and other genomic approaches. Identification of genes that modulate PPI will provide insight into the neural mechanisms underlying sensorimotor gating, as well as the psychopathology of disorders characterized by gating deficits.
authors.affiliation: Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
authors.forename: M P
authors.initials: MP
authors.lastname: Leussis
authors.forename: M L
authors.initials: ML
authors.lastname: Frayne
authors.forename: M
authors.initials: M
authors.lastname: Saito
authors.forename: E M
authors.initials: EM
authors.lastname: Berry
authors.forename: K A
authors.initials: KA
authors.lastname: Aldinger
authors.forename: G N
authors.initials: GN
authors.lastname: Rockwell
authors.forename: R P
authors.initials: RP
authors.lastname: Hammer
authors.forename: A E
authors.initials: AE
authors.lastname: Baskin-Hill
authors.forename: J B
authors.initials: JB
authors.lastname: Singer
authors.forename: J H
authors.initials: JH
authors.lastname: Nadeau
authors.forename: P
authors.initials: P
authors.lastname: Sklar
authors.forename: T L
authors.initials: TL
authors.lastname: Petryshen
mesh_terms: D000818:Animals; D001923:Brain Chemistry / Q000235:genetics*; D002874:Chromosome Mapping / Q000379:methods; D033481:Chromosomes, Mammalian / Q000235:genetics; D003433:Crosses, Genetic; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D014644:Genetic Variation / Q000235:genetics; D016678:Genome; D005838:Genotype; D006185:Habituation, Psychophysiologic / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D008818:Mice, Neurologic Mutants; D009433:Neural Inhibition / Q000235:genetics*; D040641:Quantitative Trait Loci / Q000235:genetics*; D055139:Sensory Gating / Q000235:genetics*; D013045:Species Specificity
references.citation: Psychopharmacology (Berl). 2001 Jul;156(2-3):234-58
references.pmid: 11549226
references.citation: Neuropsychology. 2003 Apr;17(2):247-54
references.pmid: 12803430
references.citation: Am J Psychiatry. 2002 May;159(5):869-71
references.pmid: 11986147
references.citation: Psychophysiology. 1997 Jul;34(4):446-50
references.pmid: 9260497
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19910-4
references.pmid: 19066216
references.citation: Genomics. 1987 Oct;1(2):174-81
references.pmid: 3692487
references.citation: PLoS Biol. 2007 Nov;5(11):e297
references.pmid: 18001149
references.citation: Neurosci Lett. 2003 Dec 15;353(1):45-8
references.pmid: 14642434
references.citation: J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):60-6
references.pmid: 8845703
references.citation: Hum Mol Genet. 2002 Jun 1;11(12):1409-19
references.pmid: 12023983
references.citation: Nat Genet. 2000 Mar;24(3):221-5
references.pmid: 10700173
references.citation: Endocrinology. 2006 Nov;147(11):5132-8
references.pmid: 16873534
references.citation: Mamm Genome. 2003 Nov;14(11):723-32
references.pmid: 14722722
references.citation: Genomics. 1997 Sep 15;44(3):266-72
references.pmid: 9325047
references.citation: Physiol Genomics. 2008 Sep 17;35(1):116-22
references.pmid: 18628339
references.citation: Mol Psychiatry. 2002;7(6):579-93
references.pmid: 12140781
references.citation: Neuropsychopharmacology. 2003 Apr;28(4):818; author reply 819
references.pmid: 12655329
references.citation: Int J Psychophysiol. 2005 Feb;55(2):229-41
references.pmid: 15649554
references.citation: Behav Genet. 1999 Jan;29(1):21-30
references.pmid: 10371755
references.citation: Psychopharmacology (Berl). 2003 Jan;165(3):270-9
references.pmid: 12426667
references.citation: BMC Blood Disord. 2006 Oct 05;6:6
references.pmid: 17022820
references.citation: Mamm Genome. 1995 Jan;6(1):8-10
references.pmid: 7719036
references.citation: Science. 2004 Apr 16;304(5669):445-8
references.pmid: 15031436
references.citation: Neuropsychopharmacology. 2008 Oct;33(11):2610-8
references.pmid: 18216776
references.citation: Neuropsychopharmacology. 2004 Feb;29(2):373-84
references.pmid: 14583743
references.citation: Nat Rev Genet. 2005 Apr;6(4):271-86
references.pmid: 15803197
references.citation: Behav Brain Res. 2007 Dec 28;185(2):76-81
references.pmid: 17765335
references.citation: Biol Psychiatry. 2001 Sep 15;50(6):418-24
references.pmid: 11566158
references.citation: Psychopharmacology (Berl). 1997 Jul;132(2):169-80
references.pmid: 9266614
references.citation: Am J Respir Cell Mol Biol. 2008 Jan;38(1):68-77
references.pmid: 17656683
references.citation: Curr Opin Pediatr. 2004 Aug;16(4):419-26
references.pmid: 15273504
references.citation: Arch Gen Psychiatry. 1999 Mar;56(3):277-81
references.pmid: 10078506
references.citation: J Neurosci. 2005 Feb 23;25(8):2157-65
references.pmid: 15728856
references.citation: Am J Med Genet. 2000 Jun 12;96(3):412-7
references.pmid: 10898924
references.citation: Cell. 2002 Sep 6;110(5):649-60
references.pmid: 12230981
references.citation: Biol Psychiatry. 2000 May 15;47(10):864-73
references.pmid: 10807959
references.citation: Psychopharmacology (Berl). 2001 Jul;156(2-3):117-54
references.pmid: 11549216
references.citation: Neuropsychopharmacology. 1999 Jul;21(1):28-39
references.pmid: 10379517
references.citation: Psychopharmacology (Berl). 2008 Aug;199(3):331-88
references.pmid: 18568339
references.citation: Pharmacol Biochem Behav. 2008 Oct;90(4):525-33
references.pmid: 18513787
references.citation: Biol Psychiatry. 2008 Jul 1;64(1):26-33
references.pmid: 18549874
references.citation: Behav Brain Res. 1997 Dec;89(1-2):35-49
references.pmid: 9475613
references.citation: Neuron. 1996 Oct;17(4):607-15
references.pmid: 8893019
references.citation: Clin Psychol Rev. 2003 Feb;23(1):95-117
references.pmid: 12559996
references.citation: Mamm Genome. 2007 Apr;18(4):221-8
references.pmid: 17492333
references.citation: Psychopharmacology (Berl). 2001 Jul;156(2-3):194-215
references.pmid: 11549223
references.citation: Arch Gen Psychiatry. 2007 Nov;64(11):1242-50
references.pmid: 17984393
references.citation: Biol Psychiatry. 1999 Feb 1;45(3):360-4
references.pmid: 10023514
references.citation: PLoS One. 2009;4(4):e5246
references.pmid: 19370154
references.citation: Neuropsychologia. 2006;44(12):2494-9
references.pmid: 16698050
references.citation: Behav Neurosci. 2008 Aug;122(4):885-900
references.pmid: 18729642
references.citation: Eur J Pharmacol. 2001 Jul 13;424(1):27-36
references.pmid: 11470257
references.citation: Brain Res. 2006 Mar 17;1078(1):168-70
references.pmid: 16492380
references.citation: J Neurosci. 1982 Jun;2(6):791-805
references.pmid: 7086484
references.citation: Biol Psychiatry. 1993 Feb 15;33(4):298-301
references.pmid: 8471686
references.citation: Behav Neurosci. 1997 Dec;111(6):1353-60
references.pmid: 9438803
references.citation: Neurobiol Aging. 2009 Oct;30(10):1693-705
references.pmid: 18280008
references.citation: Behav Genet. 2008 Mar;38(2):159-84
references.pmid: 18175213
references.citation: Behav Neurosci. 2003 Aug;117(4):716-27
references.pmid: 12931957
references.citation: Mamm Genome. 2006 Jun;17(6):598-614
references.pmid: 16783641
references.citation: Genetics. 2005 Feb;169(2):855-62
references.pmid: 15371360
references.citation: Genetics. 2006 Sep;174(1):481-9
references.pmid: 16783000
references.citation: Nature. 2006 Aug 24;442(7105):916-9
references.pmid: 16862116
references.citation: Biol Psychiatry. 2005 May 15;57(10):1153-8
references.pmid: 15866555
references.citation: Neuroscience. 1997 Oct;80(4):1075-86
references.pmid: 9284061
references.citation: Neurosci Lett. 2005 May 20-27;380(1-2):6-11
references.pmid: 15854741
references.citation: FEBS Lett. 2005 Oct 24;579(25):5704-12
references.pmid: 16219306
references.citation: Genetics. 2005 Dec;171(4):1895-904
references.pmid: 15998716
references.citation: Nature. 2006 Aug 24;442(7105):920-4
references.pmid: 16862115
references.citation: Mol Biol Cell. 2006 Nov;17(11):4619-31
references.pmid: 16914526
references.citation: J Affect Disord. 2006 Jul;93(1-3):105-15
references.pmid: 16677713
references.citation: Neuropsychopharmacology. 2002 Nov;27(5):765-81
references.pmid: 12431851
references.citation: J Neurosci Res. 2003 Nov 15;74(4):562-9
references.pmid: 14598300
references.citation: Biol Psychiatry. 2007 Dec 15;62(12):1418-22
references.pmid: 17481589
references.citation: Am J Psychiatry. 1993 Dec;150(12):1862-7
references.pmid: 8238643
references.citation: Cell. 2007 Mar 23;128(6):1077-88
references.pmid: 17320160